Quantcast

Latest Vermillion Inc. Stories

2014-06-17 16:26:07

AUSTIN, Texas, June 17, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed Dr. Judith K. Wolf to the new position of chief medical officer, effective September 15, 2014. Dr. Wolf is a highly accomplished, widely published and active professional in the field of gynecologic cancer. Over the last eight years, she has held numerous academic and administrative positions at the...

2014-05-15 16:28:30

AUSTIN, Texas, May 15, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for the quarter ended March 31, 2014. Q1 2014 Key Developments -- Formed ASPiRA LABS, Inc., a clinical laboratory which will specialize in applying biomarker-based technologies that address critical needs in the management of gynecologic cancers. ASPiRA LABS will provide diagnostic...

2014-05-08 16:28:16

AUSTIN, Texas, May 8, 2014 /PRNewswire/ -- A new research collaboration anchored by Moffitt Cancer Center in Tampa, Fla., was announced today in conjunction with World Ovarian Cancer Day. The purpose of the study is to produce clinical and economic data to support a new value-based practice model that may improve survival, quality of life and cost-effectiveness of care for patients with ovarian cancer. The study will be led by Johnathan M. Lancaster, M.D., Ph.D., a gynecologic...

2014-05-01 08:36:57

AUSTIN, Texas, May 1, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, May 15, 2014, at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2014. Financial results will be issued in a press release prior to the call. Vermillion's Chairman, President and CEO James LaFrance will host the call, followed by a question and answer...

2014-04-28 08:31:08

-Specializes in Leading-Edge Biomarker Diagnostics for Gynecologic Cancers- AUSTIN, Texas, April 28, 2014 /PRNewswire/ -- Vermillion today launched ASPiRA LABS, which will specialize in applying the latest biomarker-based technologies to address critical needs in the management of gynecologic cancers. ASPiRA LABs will provide expert diagnostic processing and results using a state-of-the-art biomarker-based diagnostic algorithm to inform clinical decision making and advance...

2014-04-23 16:30:29

AUSTIN, Texas, April 23, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed James LaFrance as president and chief executive officer, succeeding Thomas McLain. LaFrance will continue to serve as the company's chairman of the board. "Vermillion is transitioning to a phase where commercial build out and execution is of paramount importance, and Jim is best suited for this role," said...

2014-03-20 12:32:37

New Analysis Explores Interactions Between Clinical Risk Factors Used in Pre-surgical Assessment AUSTIN, Texas, March 20, 2014 /PRNewswire/ -- (Nasdaq: VRML) -- A new study of OVA1® clinical performance, titled "The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay," has been released as an online advance publication of The American Journal of Obstetrics & Gynecology.[1] The study examines the relationship between two commonly used...

2014-03-06 16:27:22

AUSTIN, Texas, March 6, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for the fourth quarter and full year ended December 31, 2013. Q4 and 2013 Key Developments -- OVA1® product revenue increased 29% to $2.1 million in 2013 versus 2012 due primarily to improved claims resolution and higher realized revenue per test. -- For the full year 2013, OVA1...

2014-03-03 16:25:49

AUSTIN, Texas, March 3, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has been invited to present at ROTH Capital Partners 26th Annual Conference being held March 10-12, 2014, at the Ritz-Carlton in Dana Point, California. President and CEO of Vermillion, Thomas McLain, is scheduled to present on Tuesday, March 11, 2014, at 3:30 p.m. Pacific time, with one-on-one meetings held throughout the...

2014-02-26 16:28:51

AUSTIN, Texas, Feb. 26, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, March 6, 2014, at 4:30 p.m. Eastern time to discuss results for the fourth quarter and year ended December 31, 2013. Financial results will be issued in a press release prior to the call. Vermillion's President and CEO Thomas McLain will host the call, followed by a question and...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.